Electra Therapeutics Inc. (ETRA) vs Anbio Biotechnology Class A Ordinary Shares (NNNN)

A side-by-side comparison of Electra Therapeutics Inc. and Anbio Biotechnology Class A Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ETRA

Electra Therapeutics Inc.

$202M

$9.54HealthcareDelayed quote: Oct 6, 2026, 12:14 PM EDT

NNNN

Anbio Biotechnology Class A Ordinary Shares

$215M

$4.89HealthcareDelayed quote: Oct 6, 2026, 12:12 PM EDT

Total return — ETRA vs NNNN

growth of $100 · dividends reinvested · last 1y

ETRA -26.5% (-26.5%/yr)NNNN -8.0% (-8.0%/yr)NNNN compounded faster over this window

ETRA NNNN

Metrics side by side

Total return (annualized)

Metric	ETRA	NNNN
Total return (1Y)	N/A	-84.84%

ETRA is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full ETRA analysis Full NNNN analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.